| Bioactivity | Anticancer agent 126 (compound 12) is a WDR5 inhibitor with anticancer effects. Anticancer agent 126 disrupts WDR5-MYC interaction in cells and reduce MYC target gene expression[1]. |
| Name | Anticancer agent 126 |
| Formula | C25H18F3N3O4S |
| Molar Mass | 513.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jian Ding, et al. Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction. J Med Chem. 2023 Jun 22;66(12):8310-8323. |
Anticancer agent 126
CAS: F: C25H18F3N3O4S W: 513.49
Anticancer agent 126 (compound 12) is a WDR5 inhibitor with anticancer effects. Anticancer agent 126 disrupts WDR5-MYC i
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.